Michael D. Feldman

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Sharat Chandran

> Home > Persons > Michael D. Feldman

Publications

2012
[j10]
- view
  authority control:
- export record
  dblp key:
  - journals/tbe/JanowczykCSSCFM12
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/tbe/JanowczykCSSCFM12
Andrew Janowczyk, Sharat Chandran, Rajendra Singh, Dimitra Sasaroli, George Coukos, Michael D. Feldman, Anant Madabhushi:
High-Throughput Biomarker Segmentation on Ovarian Cancer Tissue Microarrays via Hierarchical Normalized Cuts. IEEE Trans. Biomed. Eng. 59(5): 1240-1252 (2012)
2011
[c24]
- view
  authority control:
- export record
  dblp key:
  - conf/miip/JanowczykCFM11
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/miip/JanowczykCFM11
Andrew Janowczyk, Sharat Chandran, Michael D. Feldman, Anant Madabhushi:
Local morphologic scale: application to segmenting tumor infiltrating lymphocytes in ovarian cancer TMAs. Medical Imaging: Image Processing 2011: 79622N
2009
[c15]
- view
  - electronic edition via DOI (open access)
  - references & citations
  authority control:
- export record
  dblp key:
  - conf/miccai/JanowczykCSSCFM09
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/miccai/JanowczykCSSCFM09
Andrew Janowczyk, Sharat Chandran, Rajendra Singh, Dimitra Sasaroli, George Coukos, Michael D. Feldman, Anant Madabhushi:
Hierarchical Normalized Cuts: Unsupervised Segmentation of Vascular Biomarkers from Ovarian Cancer Tissue Microarrays. MICCAI (1) 2009: 230-238

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.